Bharat Biotech To Lead Phase 3 Trials Of Promising Shigella Vaccine
Bharat Biotech International Limited on Thursday announced a partnership with Pharma multinational GSK for the development and potential deployment of the Shigella vaccine candidate 'altSonflex1-2-3'.